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Abstract – Intramammary infections of dairy cows with Gram-positive bacteria such as
Staphylococcus aureus (major cause of mastitis) have received a lot of attention because of their
major economic impact on the dairy farm through production losses induced by an increase in somatic
cell count. Management strategies, including greater awareness for efficient milking and hygienic
measures, have limited the spread of Gram-positive bacteria and resulted in a significant decrease
of proportion of S. aureus isolates and subclinical mastitis worldwide. Other organisms such as
coliform subspecies and Streptococcus uberis, both environmental bacteria that cause clinical
mastitis, have received less attention. Escherichia coli causes inflammation of the mammary gland
in dairy cows around parturition and during early lactation with striking local and sometimes severe
systemic clinical symptoms. This disease affects many high producing cows in dairy herds and may
cause several cases of death per year in the most severe cases. It is well known that bacterial, cow
and environmental factors are interdependent and influence mastitis susceptibility. Many studies,
executed during the last decade, indicate that the severity of E. coli mastitis is mainly determined
by cow factors rather than by E. coli pathogenicity. During E. coli mastitis, the host defense status
is a cardinal factor determining the outcome of the disease. Today, we know that the neutrophil is a
key factor in the cows’ defense against intramammary infection with E. coli. Effective elimination
of the pathogen by neutrophils is important for the resolution of infection and the outcome of E. coli
mastitis. This review is a compilation of some major findings over the last 15 years concerning mainly
host factors that modulate and influence neutrophil function and the mammary inflammatory
reaction. The individual chapters address: virulence factors of E. coli strains, how neutrophils kill
E. coli, connection between endotoxins, tumor necrosis factor- and nitric oxide, severity
classification of E. coli mastitis, lifespan of neutrophils, host factors that influence severity, tissue
damage and production loss. 
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1. INTRODUCTION
Escherichia coli causes infection and
inflammation of the mammary gland in
dairy cows mainly around parturition and
during early lactation with striking local
and sometimes severe systemic clinical
symptoms. This so-called environmental
type of mastitis may affect productivity of
high producing cows in dairy herds. It may
also cause several deaths per year in the
most severe cases. E. coli invades the udder
through the teat canal where it grows and
initiates a prompt inflammatory reaction,
Severity of E. coli mastitis in dairy cows 523
with increasing numbers of neutrophils
appearing. This neutrophil infiltration is
one of the first steps of the inflammatory
reaction because they have to prevent
escape and multiplication of the pathogens. 
It is well known that bacterial, environ-
mental or management, and cow factors
may change susceptibility for mastitis.
These factors are interdependent and espe-
cially the relative impact of each factor
depends on the type of pathogen [234].  
1.1. Pathogen factors
The pathogenesis of coliform mastitis is
completely different from diseases such as
colibacillosis in calves and pigs. For exam-
ple, it is well known that in so-called entero-
toxigenic E. coli (ETEC) strains, the
colonisation of intestinal mucosa is related
to the expression of several different pro-
teinaceous surface structures, i.e. colonisa-
tion factors, which recognise specific
receptors on the intestinal epithelial surface
[47, 206]. The pathogenicity in these ani-
mals mainly depends on expression of par-
ticular virulence factors. For coliform
mastitis this is not the case, and it is gener-
ally accepted that the type of E. coli strain
does not play a major role in the severity
classification [24]. A non-specific but
potent factor that is important during the
pathogenesis of E. coli is the endotoxin or
lipopolysaccharide (LPS) [64]. At the one
hand it induces defence mechanisms and at
the other hand it is a toxic compound.
Pathophysiological effects of endotoxins in
ruminants are dose-dependent and elicit a
variety of metabolic and clinical signs [143,
144]. 
1.2. Management factors
Management factors that influence the
cow’s condition during late pregnancy,
mainly with respect to energy, in order to
achieve a fast and high peak of milk pro-
duction, might be the cause of metaboli-
cally immunocompromised cows that have
lower resistance to stress induced by partu-
rition and early lactation. Once adapted, i.e.
after peak lactation, it seems that cows are
less susceptible for environmental patho-
gens. 
The organised control of bulk and cow
milk samples by specialised milk quality
centres has resulted, especially in Europe,
in a significant reduction in normal somatic
cell count (SCC). There is a tendency
to believe that low milk SCC fails to pro-
tect the udder from environmental patho-
gens (reviewed by [227]). This finding is
mainly based on epidemiological data and
there are only a few experimental data that
can confirm these findings (e.g. [210]).
Finally, higher stock densities have resulted
in a greater pasture contamination with eas-
ier access for environmental pathogens to
the udder through their open teats during
calving and early lactation. Management
factors fall beyond the scope of this review.
1.3. Cow factors 
The ability of neutrophils to sequester
and kill the pathogens is a critical step
in the defence reaction against E. coli.
The progress of the inflammatory reaction
is determined by a constitutive balance
between forces opposing pathogen growth
and production of virulent factors, and the
forces favouring it. Neutrophils are very
beneficial to the udder following E. coli
infection, and form the most important
body defence mechanism. It is essential
that they arrive in the lumen of the udder
promptly if they are to be totally effective.
Since 1990, numerous reviews have been
written summarising and updating the
progress toward the understanding of the
mechanisms of the neutrophil response
into udder tissue and cistern during E. coli
mastitis [31–33, 177, 179]. More recently,
excellent reviews have been published in
connection with the immune mechanisms
in the mammary gland [119, 180, 220]. It is
well recognised that clinical E. coli masti-
tis cases occurring during established lac-
tation show a minimum of systemic signs
(such as fever, discomfort, temporary milk
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production drop, etc.). Clinical signs are
moderate, subside very rapidly and the ani-
mal cures itself. Under these conditions,
the inflammatory reaction has to be consid-
ered as a 100% physiological reaction. It
seems that at parturition and during early
lactation, high producing cows are more
sensitive for infection with common envi-
ronmental pathogens such as E. coli. Many
factors may have contributed to this phe-
nomenon but the animals’ physiological
pre-infection status also influences the out-
come of coliform mastitis. 
From many studies performed during the
last 15 years, it is evident that the severity
of bovine E. coli mastitis is mainly deter-
mined by cow factors rather than by the
pathogenicity of the invading pathogen.
During coliform mastitis, the host defence
status is a cardinal factor determining the
pathogenicity and the clinical outcome of
this disease, depending on its interaction
with the pathogen and its LPS. In this
review some aspects will be covered of
LPS in relation with severity of coliform
mastitis. 
Initiation and resolution of inflamma-
tion is controlled by a complex network of
biological substances that belong to the
homeostatic armamentarium of the host.
Since 1990 a long list of original papers,
dealing with the impact of the physiology
of the cow (parturition, lactation stage, age,
metabolism, pro- and anti-inflammatory
endogenous substances, growth factors,
platelet activating factor, etc.) on the patho-
genesis of mastitis, have been published.
Each imbalance in initiation, tuning and
resolution results in host and/or tissue dam-
age and severe prognosis of the disease. 
As a consequence of neutrophil infiltra-
tion into the invaded area of the mammary
gland, changes in blood cell composition
occur, due to bone marrow stimulation
and alteration of the normal venular equi-
librium that controls attachment, rolling
and diapedesis. Next to the changes in
the cellular blood picture, composition of
extracellular water (internal sea; [37]) also
changes. The concept of a well-balanced
inflammatory response where pro- and
anti-inflammatory local mediators, such as
cytokines, regulate the outcome of the
inflammatory process, is also applicable to
systemic factors [34].  The inflammatory
reaction is a rapid and mainly a non-specific
defence that is accompanied by the release
and/or “de novo synthesis” of specific and
non-specific molecules, such as systemic
and tissue hormones and (poly)peptides.
The metabolism of the animal is also
changed. Hormones, metabolites and acute
phase proteins, may influence the outcome
of mastitis. 
Curing (the final goal of the inflamma-
tory reaction) of the mammary gland is
only successful if minimal host and tissue
damage occurs. Therefore, the inflamma-
tory reaction has to be fast, short lasting and
regulated. After elimination of the invading
pathogens, neutrophil reaction subsides to
promote a predominant mononuclear cell
picture. Macrophages do not only replace
neutrophils but also actively participate in
their removal [181]. This last step repre-
sents the resolution of the inflammatory
reaction. Neutrophil infiltration and resolu-
tion during E. coli mastitis are necessary to
reset the composition of the “internal sea”
towards the pre-infection status of the
organism and this is accompanied by spe-
cific and non-specific systemic events.
This is in agreement with the general
concepts in physiology [37].
This chapter is a compilation of some
major findings over the last 15 years con-
cerning mainly host factors that modulate
and influence neutrophil function and the
inflammatory reaction of the lactating cow.
The individual chapters are dealing with
virulence factors of E. coli mastitis strains,
how neutrophils sequester and kill E. coli,
the connection between endotoxins, tumor
necrosis factor- (TNF-) and nitric oxide
(NO), severity classification of coliform
mastitis, lifespan of neutrophils (from mat-
uration to senescence), host factors that
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influence severity, tissue damage and pro-
duction loss. 
2. VIRULENCE FACTORS
OF E. COLI MASTITIS STRAINS
2.1. E. coli as pathogen
E. coli is a member of the family of
Enterobacteriaceae. Of primary impor-
tance is their ability for fermentation of lac-
tose. Over 700 antigenic types or serotypes
of E. coli have been recognised based on O,
H, and K antigens. Two classes of coliforms
have to be distinguished: strains that are
harmless (non-pathogenic strains) and
strains that cause a wide variety of typical
clinical infections (pathogenic strains,
[47]). Millions of non-pathogenic E. coli
bacteria are living in the normal intestinal
microflora of both humans and animals.
E. coli adheres to the mucus overlaying the
large intestine where they constitute a use-
ful microbial barrier because of their antag-
onism to pathogenic bacteria. E. coli is
massively excreted with the faeces in the
environment. E. coli is ubiquitous in the
cow’s environment. It is obvious that chal-
lenge of E. coli udder infection will remain
so long as cows produce faeces [112]. They
behave as opportunistic pathogens. There
has been a substantial rise in the incidence
of E. coli mastitis since 1960 and it is
accepted to be the most common cause
of fatal mastitis [163]. In contrast to the
enteropathogenic and bacteraemic strains,
which are caused by a relatively low
number of E. coli serotypes [47], the iso-
lates from bovine coliform mastitis belong
to a very large number of serological
groups. E. coli serotypes in mastitic milk
are similar to the faecal isolates. There are
a very large number of E. coli serotypes as
classified by surface antigens but the inner
layer of the cell wall is common to all sero-
types of E. coli and Enterobacteriaceae in
general [65].
2.2. Adhesion and colonisation
Following experimental intramammary
(I.M.) challenge with E. coli, attachment to
mammary epithelium was not observed
[136]. Electron microscopic research on
the pathogenesis of coliform mastitis never
revealed attachment of bacteria to the epi-
thelium [24]. Attachment of E. coli to
mammary epithelial cells seems not to be
essential for the pathogenesis of clinical
coliform mastitis [76, 175]. Most of masti-
tis pathogen adhesion studies have been
performed with cell cultures for which sev-
eral models have been described. Lammers
et al. [132] used E. coli strain HB101 as
negative control to test adhesion and inva-
sion of udder pathogens. In a recent study,
the specificity and efficiency of adhesion
of 11 different E. coli strains was studied.
The cell tropism of the tested E. coli strains
was strongly strain-dependent and very
variable from very low to high efficiency
[133]. Binding can also occur to molecules
of the cell matrix and Ditcham et al. [58]
emphasised the need for an epithelial
model that reflects as closely as possible
the in vivo situation i.e. intact and unstim-
ulated epithelium with no expression of
extracellular matrix. 
Fibronectin, a glycoprotein of high
molecular weight, is produced by mamma-
lian cells in tissue culture [170]. Faris et al.
[72] tested the ability of 70 E. coli strains,
isolated from bovine mastitis in Australia,
Denmark, Norway and the USA, to bind
fibronectin in vitro. Fifty-three strains
(76%) interacted with iodinated fibronectin
at a level exceeding 5% of the total radio-
activity added. In a recent study of Lam-
mers et al. [133] 11 E. coli mastitis strains
bound fribonectin to approximately the
same extent as a fibronectin binding Sta-
phylococcus strain with impaired fibronec-
tin-binding protein expression (20% of the
wild type). None of the tested E. coli strains
was able to bind fibronectin efficiently. It is
known that in the normal mammary gland
fibronectin is not present at the apical side
of the epithelium. In the gland it is a normal
526 C. Burvenich et al.
component of the basement membrane of
the epithelium where it is present as an
insoluble matrix. It is also present at the
surface of myo-epithelial cells and fibro-
blasts. LPS increases cell surface-associ-
ated fibronectin in fibroblasts in vitro [127].
Frost et al. [78] showed that two hours after
I.M. infection with E. coli, epithelial lesions
occurred in the teat sinus. The basement
membrane was exposed [26] but lesions
never went beyond the basal membrane. 
It is clear that E. coli is primary an extra-
cellular pathogen that is involved in I.M.
infection [97]. Most studies dealing with
the capability of E. coli, isolated from clini-
cal mastitis, to adhere to mammary epithe-
lia, do not indicate any important role for
adherence. The organisms generally do not
invade mammary tissue but remain in the
lumen of the teat canal and lactiferous
sinus. According to our current knowledge
it is clear that the pathogenicity of coliforms
isolated from acute mastitis cases is not
related to invasion and/or colonisation.
The role of these virulence factors is less
clear in cases of chronic coliform mastitis
[66]. Binding of E. coli to fibronectin in
vivo, remains questionable. The greater
residual number of bacteria in the gland
after milking when compared to the previ-
ous milking, indicates that infection has
progressed and the faster the bacteria mul-
tiplicate, the higher their numbers will be,
but colonisation is not necessarily involved
[23]. In the field, it is generally accepted
that frequent milkout of E. coli infected
cows is helpful for the treatment of
coliform mastitis. In a recent study, the
effect of frequent milkout was tested on
the outcome of experimentally induced
E. coli mastitis in cows. However, under
these conditions, frequent milkout did not
appear to be an efficacious treatment for
moderate to severe E. coli mastitis [137],
indicating that the bacteria replicate very
fast. 
During clinical coliform mastitis it can
not be excluded that temporary reversible
attachment of the E. coli pathogen occurs
on the intact epithelium of the lactiferous
sinus. This can not be defined as adhesion
because this association is not followed by
any specific receptor-mediated binding and
colonisation as seen in the gut with entero-
pathogenic E. coli strains. Most studies
show that adherence of E. coli pathogens to
the epithelium does not exist or is at very
least weak. However, such a reversible
binding could eventually trigger secondary
mediator release of cytokines that attract
inflammatory cells. MAC-T cells (a non-
differenciated bovine mammary epithelial
cell line, [107]) secrete IL-1 in response to
endotoxin stimulation and IL-1 is an
important mediator for the release of the
bovine IL-8 by MAC-T cells [20]. NO
release from mammary epithelial cell lines
was also measured in response to endo-
toxin [21].
2.3. Endotoxin as local mediator 
Virulence of coliforms and the induction
of an inflammatory reaction depend on
their ability to replicate in the organism and
to destroy cellular structures. During mul-
tiplication, destruction and lysis, they
release an outer-membrane component, the
endotoxin or LPS [68], a thermostable mol-
ecule that is a unique structural component
of the cell wall of the Gram-negative path-
ogens. Two phenotypic forms of coliforms
with slightly different LPS can be distin-
guished: smooth with complete LPS side-
chains and rough with incomplete LPS
side-chains [65, 154, 169]. Many studies
have shown that the pathogenicity of E. coli
in the mammary gland is associated with
LPS. LPS is considered to be a key mole-
cule in the pathogenesis of this disease
[41]. This is based on the following facts:
(1) LPS is released as a result of the lysis
and growth of E. coli in the lactiferous
sinus [68]. Once the bacteria reach the teat
cistern they will grow very fast, 8–10 fold
increase every two hours, releasing a lot of
LPS. (2) I.M. administration of LPS
induces the same local signs as observed
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during E. coli mastitis [53, 176]. (3) Pre-
treatment with polymyxin B (an LPS neu-
tralising agent) or its simultaneous admin-
istration reduces and delays the febrile and
leukopenic responses to I.M. LPS, and pre-
vents the reduction in plasma zinc [262].
LPS is responsible for many pathophysio-
logical signs observed during Gram-nega-
tive bacterial infections in ruminants such
as fever, changes in the number of circulat-
ing leukocytes (leukopenia, leukocytosis),
complement activation, activation of mac-
rophages, increase of venular permeability,
changes in plasma levels of metabolites,
minerals, acute phase reactants and hor-
mones, etc. LPS induces a defence response,
especially in low doses. Intravenous admin-
istration of high doses of LPS may produce
lethal shock [143, 144]. 
Although the pathogenic potential of
purified bacterial LPS is well documented
in general, the role of LPS in the pathogen-
esis of coliform mastitis has not been com-
pletely resolved. At the one hand there is no
doubt that locally released LPS may play an
important role in many of the local inflam-
matory signs during coliform mastitis [31].
However, it seems that its influence is short
lasting and that it does not necessary cover
all inflammatory changes. For example, the
pre-treatment with polymyxin B only mar-
ginally influenced the degree of udder
inflammation and it had no effect on the
increase in SCC [262].  Twenty years ago
Brooker et al. [26] already showed that two
toxines were involved in experimentally
induced E. coli mastitis: (1) the endotoxin,
and (2) a heat labile cytotoxic compound
that appears in a filtrate of E. coli culture.
At that time Brooker et al. [26] already men-
tioned that the generally accepted concept
that I.M. infusion of LPS produces a reac-
tion indistinguishable from E. coli is not
justified.   
2.4. Endotoxin as systemic mediator
I.M. infusion of polymyxin B at 30 or
60 min after LPS only prevented the
increase in plasma lactate dehydrogenase
(E.C.1.1.2.3) activity and moderated the
decrease in plasma zinc concentration. This
treatment failed to alter the clinicopatho-
logic course of endotoxin-induced acute
mastitis [262]. The possible absorption of
LPS from the inflamed udder during coli-
form mastitis into the general circulation,
and its significance at systemic level is not
so clear and has been discussed in literature
during the last decades (see e.g. [144]).
LPS was detected in the plasma of 3 out of
12 cows during the first 10 h after I.M.
E. coli challenge. Thereafter, only low LPS
concentrations were detected in blood
plasma. LPS concentrations of 55, 134 and
93 pg/mL were reached for a very short
lasting period [64]. This short lasting event
might be due to a fast clearance of LPS
in plasma or to a limited release of LPS
from the mammary gland into the circula-
tion. The values corresponded with those
obtained from naturally occurring gangre-
nous E. coli mastitis [89], in which 85 ±
68 pg LPS/mL was detected in blood
plasma. The sporadic detection of limited
LPS amounts in plasma contrasts with the
massive LPS amounts that are released in
the mammary gland during E. coli mastitis
[246]. In the LPS model, the inflammatory
reaction is induced by “bolus injection”; in
the E. coli infection model, LPS is released
during several hours [64, 93, 97, 124, 161,
167, 210, 244, 245]. Most LPS mastitis
models described in literature are per-
formed after peak lactation. In these
“bolus” LPS mastitis studies, LPS seems to
be effectively detoxified, and low levels of
cytokines, produced during the inflamma-
tory process, are the primary cause of the
moderate systemic effects. The defence
mechanism of the animal is not compro-
mised at that moment. Milk production loss
is less pronounced during LPS mastitis
than during E. coli mastitis. Milk produc-
tion losses in the uninflamed quarters are
negligible in LPS mastitis, but substantial
during E. coli mastitis (more pronounced
systemic effects). Reticulorumen motility
is only inhibited during E. coli mastitis
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and changes in plasma haptoglobin are
more pronounced during E. coli mastitis,
although they occurred sooner during LPS
mastitis [143, 144]. 
In a recent study, LPS mastitis was
induced in high yielding Holstein cows, 5–
12 weeks after parturition, by I.M. infusion
of 500 µg into one quarter. The first milk
sample was taken 4 h after I.M. LPS chal-
lenge and contained elevated LPS levels.
These LPS levels gradually decreased over
the entire course of the experimental period
[258]. The data of I.M. increase of LPS  are
in agreement with those obtained by Ziv
et al. [261] and Hartman et al. [92], who
also found an increase of LPS in blood
plasma. However, in the study of Yagi et al.
[258] no LPS could be detected in serum
obtained from the milk vein or the jugular
vein, which is more compatible with current
concepts. The discrepancies between the
results obtained in the study of Ziv et al.
[261] in the ‘70s and the recent study of
Yagi et al. [258] are not inexplicable. Under
field conditions, coliforms have been iso-
lated in blood samples from diseased ani-
mals [253]. To our best knowledge, this has
not been confirmed in experimentally
induced coliform mastitis [190, 208] but
this finding certainly needs more attention
in the future. Especially the interplay
between mediators from bacterial origin,
such as endotoxins and non-LPS toxins,
and the release of endogenous mediators
(e.g. TNF-) during coliform septicaemia
in the cow should be focused.
2.5. Endotoxin clearance
In the study of Dosogne et al. [64] E. coli
counts were about 2105 colony forming
units (cfu)/mL milk. The LPS release from
E. coli during a 6 h growth period was
16.8 µg (inoculum size of 105 cfu/mL,
[235]). The calculated amount of LPS in
milk from infected quarters was approxi-
mately 105 times higher than the highest
LPS value observed in blood. This suggests
that a very large proportion of LPS is
detoxified locally inside the inflamed mam-
mary gland during E. coli mastitis, probably
by neutrophils. A significant detoxification
system is acyloxyacyl hydrolase (AOAH),
which is present in bovine neutrophil gran-
ules [154]. AOAH hydrolyses two acyl
chains of the lipid A core of the endotoxin,
resulting in a decreased toxicity whereas
the immunogenic properties of LPS are
largely maintained [169]. In some cows, a
decreased blood neutrophil AOAH activity
was observed immediately after calving
[60]. The fact that LPS was only detected
in the plasma of animals with the highest
cfu counts in milk suggests that LPS
absorption is probably to a high extent
dependent on the number of bacteria within
the mammary gland and can therefore also
be prevented by bacterial growth inhibition
[64]. In the case LPS is absorbed from the
udder into the systemic circulation (outside
the portal hepatic system), it will reach the
lung circulation first and activate the pul-
monary alveolar macrophages. In this way
the effective inactivation capacity by the
von Kupffer cells of the liver is evaded. The
same phenomenon occurs when the ability
of the liver to eliminate LPS fails due to
liver disease [36]. The general phrase that
animals suffering from coliform mastitis
show signs of endotoxinemia should be
avoided. In fact they rather show signs of
toxinemia caused by TNF-. Endotoxine-
mia is probably more the exception than the
rule. Many animals however, may rather
suffer from a mediator shock. The highest
amounts of blood plasma TNF- are found
in severely diseased cows [98, 102]. There
are various indications that LPS might not
be released from the mammary gland into
the general circulation during LPS mastitis
(discussed in [102, 143, 144]). 
3. HOW NEUTROPHILS 
SEQUESTER AND KILL E. COLI 
The first line defence mechanism against
E. coli invading the mammary gland is
based on the resident phagocytes, mainly
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mononuclear cells. Most chemotactic fac-
tors are produced by the host but also some
bacterial factors act as chemoattractant
(e.g. the LPS of E. coli). However, unlike
human neutrophils, bovine neutrophils
lack the formyl-methionyl-leucyl-phenyl-
alanine (fMLP) receptor [228]. After a
complicated cascade of release of biologi-
cal substances and activation of the
endothelium, neutrophils migrate into the
mammary gland and finally also appear in
the fluid of the lactiferous sinus [31]. Sev-
eral antimicrobial systems exist in the
mammary gland [31, 119, 178]. However,
it is the massive influx of neutrophils that
will resolve the infection through seques-
tration and killing of the invading bacteria
[31, 180].
Immunological recognition is mainly
accomplished by specific antibodies (IgG2
and IgM) which recognise the bacterium
through Fab-regions and bind to PMN via
Fc-receptors on the PMN plasma mem-
brane [177]. There is a synergy between the
Fc and C3b receptors activity and PMN
reactive oxygen species (ROS) production
[171]. Targowski and Niemialtowski [229]
observed an increased Fc receptor expres-
sion and phagocytosis after in vitro migra-
tion of bovine PMN through membranes.
This was confirmed in further studies by
Berning et al. [12] and Worku et al. [257].
During migration of PMN into milk in
response to E. coli, increased binding of
C3b was observed [54]. Following adher-
ence of E. coli to surface receptors on the
PMN, phagocytosis and respiratory burst
are triggered. The process of opsonisation,
though not essential for phagocytosis,
certainly promotes the uptake of E. coli
by PMN, which is energy-dependent and
requires the presence of a functional cytoskel-
eton [103]. The cytoskeleton machinery,
sequentially activated following receptor
stimulation, is thought to envelope the
micro-organism in a “zipper mechanism”
[86]. Thus, PMN are fully armed to confront
invading E. coli. Generally, there are two
different microbicidal mechanisms within
the PMNs: the oxidative and the non-oxi-
dative system.
3.1. Oxidative mechanism of E. coli 
killing
Within seconds after the recognition of
E. coli, PMN become activated and gener-
ate powerful reactive oxygen species, such
as superoxide anions (O2–), hydrogen per-
oxide (H2O2), halogen reactive species and
hydroxyl radicals (°OH) by partial reduc-
tion of O2 [138]. This process is linked to
the respiratory burst and associated with
the PMN’s cell membrane and granules
(e.g. [8, 13, 196, 221]). Many different
mechanisms of oxidation-reduction reac-
tions are involved in intracellular bacterial
destruction [194, 252]. The oxygen-
dependent mechanism is the most promi-
nent mechanism for E. coli destruction
[222, 228]. Baldridge and Gerard [9]
reported that an increase in O2 consump-
tion by PMN takes place when phagocyto-
sis is triggered. This coincides with the
increase of the hexose monophosphate
shunt activity and glucose consumption.
The respiratory burst is based on the acti-
vation of a membrane-bound oxidase
(NADPH-oxidase), which catalyses the
following reaction [7, 198, 199]:
.
The oxygen molecule is central in this phe-
nomenon [3, 7, 8]. Its importance was high-
lighted by inefficient PMN bactericidal
activity under anaerobic conditions [150].
For each molecule of O2 consumed 4 O2–
ions are generated, resulting in an intravac-
uolar O2– release of about 4 mol/L [194]. 
Another O2-dependent microbicidal sys-
tem uses halides and the enzyme myeloper-
oxidase (MPO, E.C. 1.11.1.7). MPO and/or
eosinophil peroxidase catalyses the reac-
tion between H2O2 and Cl–, I–, or Br–, with
formation of the highly toxic hypohalides
and the subsequent oxidation of amines
[7, 198, 199]. MPO is localised in the
azurophilic granules of the PMN and
2O2 NADPH+ 2O2
– NADP+ H++ +
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reaches the micro-organisms when the
granule content is released into the phagolys-
osome [44], providing a destructive envi-
ronment for phagocytosed E. coli. Among
these ROS are also a variety of oxidised
halogens, including hypohalite ions [4,
196, 233] and a variety of chloramines
[232]. 
Root and Cohen [196] have suggested
several possible direct sites of action for
ROS, related to their microbicidal activity.
These include: (1) unsaturated carbon
bounds that may lead to toxic lipid peroxi-
dation; (2) sulphydryl groups leading to
the destruction of sulphydryl containing
enzymes; (3) amino group and possible
peptide bound breakage; and (4) nucleic
acids. In vitro studies with O2– generating
systems such as xanthine oxidase [197]
suggest that O2– are far more toxic for
E. coli if they operate in the MPO-H2O2 -
halide system. This leads to the production
of powerful halogenated oxidising agents
such as ClO– ions, which have a bacteri-
cidal effect by halogenating the bacterial
proteins. The halogenated oxidising agents
are produced inside the phagosome when
PMN ingest bacteria [44]. It is also gener-
ally agreed that ROS boost oxygen-inde-
pendent microbicidal activity [194].
Nitrogen oxide also acts as an antimicro-
bial agent in the presence of ROS [130]. It
synergises bactericidal activity of H2O2
against E. coli by damaging the E. coli DNA
and declining bacterial glutathione contents
[182]. In human, NO release is a part of the
integrated response of PMN stimulated by
phorbol-myristate-acetate (PMA, an ester
that activates the NADPH-oxidase in the
cell membrane). NO together with O2– pro-
duces other oxidants, such as peroxinitrite
(ONOO–; [40]).   
3.2. Non-oxidative mechanisms 
of E. coli killing
Non-oxidative mechanisms of bacterial
killing by bovine PMN are less well
defined, but they heavily rely on the ability
of PMN’s enzymes and proteins to alter the
membrane permeability of E. coli [191,
207]. Studies have demonstrated that a
cationic bactericidal/permeability-increas-
ing protein (BPI) present in both rabbit and
human PMN is the basic non-oxidising bac-
tericidal agent of these PMN toward several
strains of E. coli bacteria [70, 251]. Bovine
lactoferrin has also considerable inhibitory
effect on E. coli growth [15]. Moreover,
extracellular matrix proteins such as
laminin promote neutrophil motility and
attachment to E. coli, enhance phagocytosis
activity of neutrophils, substantially prime
neutrophil ROS production and stimulate
lysozyme release into the phagosome [188,
230]. Lysozyme has the capacity to neutral-
ise and strongly interact with E. coli LPS
[173]. Laminin also enhances the neu-
trophil bactericidal activity against E. coli,
the effect being larger with increasing IL-1
and IL-8 concentrations. Also fibronectine
enhances the bactericidal activity, syner-
gised by TNF- [213]. The cytosin-
dependent cell-mediated bactericidal activ-
ity of PMN is also crucial for killing of
E. coli, especially during the early phase of
E. coli mastitis.
Another non-oxidative antimicrobial
agent is PMN elastase. Elastase degrades
the outer membrane protein A of E. coli,
which is located on the surface of the bac-
teria [11, 250]. Mice lacking PMN elastase
and other granule-proteases are more sen-
sitive to E. coli infection [10] and other
bacterial and fungal infections [194]. Acti-
vation of proteases provokes the influx of a
large amount of ROS into the phagolyso-
some, resulting in a strong anionic charge.
This leads to the release of cationic gran-
ule proteins, facilitating the bactericidal
process. The anionic charge is compen-
sated by a K+ flux from cytosol into the
phagosome [194]. The large amount of K+
in the phagosome is a crucial factor for the
non-oxidative bactericidal activity by its
effect on proteases and pH homeostasis
[111, 153, 194]. 
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The osmotic forces in the vacuole must
be considerably high to enable the shrink-
age of ingested bacteria (about 50% of their
original volume). Osmotic forces also acti-
vate PMN granule proteases [194]. High
extracellular osmolarity decreases the kill-
ing capacity of PMN against E. coli [90].
Many other factors such as calcium ions
[139], granulocyte colony-stimulating fac-
tor (G-CSF) [134], growth hormone and
insulin-like growth factor (IGF)-I [108]
enhance PMN killing capacity against
E. coli. 
In short, successful intracellular killing
of E. coli depends on ROS production.
Bovine blood and milk PMN ROS produc-
tion can be measured by chemiluminescence
(CL; see [157–159]), which is associated
with the bactericidal capacity of PMN [3,
84, 187, 249]. Studies on CL kinetics in
PMN revealed extra- and intracellular
events during ROS production [25, 49, 69,
73]. Figure 1 provides a scheme of a
hypothesis showing extra- and intracellu-
lar ROS production of PMN in relation to
possible tissue damage or effective killing
Figure 1. Diagram illustrating the hypothesis that during severe E. coli mastitis extracellular
production of reactive oxygen species (ROS) by polymorphonuclear leukocytes may be impaired
and contribute to the tissue damage. Normally, ROS for bactericidal activity is produced
intracellularly for effective destruction of bacteria with a minimum of tissue damage. This
hypothesis is based on the study of the kinetics of chemiluminescence: (1) there is a difference
between extracellular and intracellular ROS production of both blood and milk PMN during
different stages of lactation, and (2) in blood and milk, extracellular ROS production by PMN is
more pronounced in older cows. This may lead to an impaired bactericidal capacity of resident milk
PMN and boost tissue damage in older cows [158, 161].
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depending on some physiological parame-
ters (age and lactation stage). This hypoth-
esis is based on findings from studies
performed on healthy and experimentally
infected cows [158, 161]. A low ROS pro-
duction of resident milk PMN is observed
during early lactation. This is more pro-
nounced in older cows where most of ROS
is produced extracellularly. This may com-
promise milk PMN bactericidal capacity
and boost tissue damage. Our preliminary
findings indicate that during E. coli masti-
tis both extracellular and intracellular ROS
substantially increase from 6 to 48 h post-
infection. The studies may suggest that in
moderate responders, ROS is mainly pro-
duced intracellularily whereas in severe
responders it is extracellular ROS. 
The above explanation is a general basic
knowledge about killing of E. coli and is
not the whole explanation about PMN–
E. coli interactions during and after phago-
cytosis. There are interspecies differences
as well as inter-subspecies differences on
oxidative and non-oxidative PMN bacteri-
cidal mechanisms [225, 228].
4. THE LPS, TLR 4, TNF- 
AND NO CONNECTION
Peptidoglycan monomers and LPS are
unique to all Gram-negative cell walls.
They are elements of the pathogen associ-
ated molecular patterns (PAMP) and bind
to pattern-recognition receptors (PRR) that
are present on a variety of defence cells of
the body causing them to synthesise and
release a variety of cytokines. The LPS
interacts with LPS-binding protein and
CD14, which in turn promotes the ability of
the Toll-like receptor, TLR4 (a PRR) on
macrophages to respond to the LPS with
the release of various pro-inflammatory
cytokines. These inflammatory mediators
bind on target cells via specific receptors
and initiate inflammation. Toll-like recep-
tor proteins, homologues of the Drosophila
protein Toll, have been detected on the sur-
face of mammalian cells [14]. They are
important in the responses of macrophages
to bacterial, viral, and fungal antigens.
TLR2 and TLR4 have candidate genes for
resistance to several diseases as they recog-
nise broad classes of PAMPs, such as
peptidoglycans and LPS [254]. Very little
TLR4 is present on the surface of human
neutrophils. TLR2 is important for response
to Gram-positive bacteria, bacterial pep-
tides and zymosan and is more abundant on
the neutrophil. TLR4 activates the inflam-
matory gene expression through nuclear
factor B (NFB) [156]. Granulocyte-mac-
rophage colony-stimulating factor (GM-
CSF) and granulocyte colony-stimulating
factor (G-CSF) dramatically up-regulate
TLR2 and CD14 expression [129].  Recent
in vitro studies have shown that mammary
epithelial cells may participate in the immu-
noregulation during mastitis via cytokine
production. A MAC-T cell line was utilised
to investigate the expression of interleukin-
1 mRNA and its subsequent secretion after
E. coli LPS stimulation and it showed that
these cells secrete IL-1 in response to LPS.
IL-1 also appeared to be an important
mediator for the release of the IL-8 [20,
107]. 
During coliform and LPS mastitis in
ruminants, IL-1, IL-6 and IL-8 [210],
platelet-activating factor [184], prostag-
landins [5, 27, 186], activated complement
C5 (C5a; [211]) and NO [16, 19], are
released locally. In milk, an increase in
TNF-, a cytokine of particular interest in
the pathogenesis of E. coli mastitis, is
observed [98, 102, 211, 219]. The increase
in TNF- occurs faster during LPS masti-
tis than during E. coli mastitis but it peaks
higher during I.M. E. coli infection. TNF-
remains unchanged in non-challenged quar-
ters [16, 102]. Absorption of this cytokine
into the systemic circulation is highest dur-
ing E. coli mastitis. Plasma levels are much
lower than in the milk and correspond with
maximal pyrexia [102]. Several studies
show that the amount of TNF- released in
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milk correlates with the severity of the dis-
ease [16, 98, 102, 210, 219].
Many of the biological activities of LPS
are mediated by TNF-. LPS and cytokines
stimulate the synthesis of NO, which is a
vasodilator. NO is a diatomic free radical.
It is lipid soluble and diffuses easily
through cell membrane. It is short lived and
usually degrades or reacts within a few sec-
onds. The natural form is a gas that reacts
with a variety of molecules and mediates a
large spectrum of biological effects. NO is
synthesised from L-arginine. An inducible
NO synthase (E.C. 1.14.13.39, iNOS) is
expressed by a variety of cells, especially
monocytes, as a result of triggering with
substances of microbial origin such as LPS
and TNF-. Bovine monocytes produce
NO in response to LPS [1, 114, 223]. NO
is produced by macrophages in response to
invading pathogens and acts as an antimi-
crobial agent. It is also cytotoxic and can
induce apoptosis if produced in excessive
amounts [6, 166]. 
Several studies on ruminants have
shown a relationship between LPS, TNF-
and production of NO. The increase in
TNF- is followed by a delayed increase in
NOx (NO2 + NO3) [16, 19]. The NOx pro-
duction lasts longer in E. coli challenged
quarters. A causal relationship between
TNF- and NOx production was observed
in studies in which E. coli LPS was injected
intravenously [115]. It seems that severe
cases of coliform mastitis are accompanied
by the highest increase in blood plasma con-
centrations of both TNF- and NOx [16,
98]. The increase in NOx and TNF- during
E. coli mastitis can’t be inhibited by antibi-
otic treatment [16] indicating that its release
is LPS mediated. Initially called endothe-
lium derived factor (EDRF), NO causes
vasodilation. It is released after the fever
peak, that is, at the moment of the delayed
phase of vasodilation occurring during LPS
induced mastitis in lactating goats and cows
[53]. It is not impossible that NO is involved
in this delayed phase of hyperemia.
5. SEVERITY CLASSIFICATION 
OF COLIFORM MASTITIS
5.1. Clinical severity classification
Mastitis is a multifactorial disease and its
risk factors can be classified into three
groups of disease determinants: the patho-
gen, the environment and the host [234]. To
combat mastitis, sophisticated models,
such as the five-point-plan, have been
adopted worldwide and have resulted in
significant reduction of subclinical masti-
tis. However, despite classical efforts for
control and prevention, the susceptibility of
cows to coliform infection is increasing
[131, 205, 224]. Moreover, from both epi-
demiological and experimental studies it
can be concluded that severity of coliform
mastitis is of much more concern than its
incidence. Many high producing cows are
extremely sensitive for E. coli infections
around parturition and during early lacta-
tion. Clinical mastitis with grave systemic
symptoms occurs at parturition and during
early lactation, whereas during mid and late
lactation signs are mild to moderate [97].
Estimation of the sensitivity of a cow for
I.M. E. coli infection refers to its clinical
expression. In the field, these signs are
ranked from mild, to moderate and severe,
and resistant animals are insensitive.
Severe clinical mastitis is characterised by
sudden onset with grave systemic signs:
diarrhoea, inhibition of rumen motility,
paralysis, hypothermia, very high pulse rate
and hypersalivation. It is well recognised
that the severity of coliform mastitis deter-
mines the outcome of the disease as well as
the degree of production loss. Therefore,
accurate evaluation of the severity in the
field is needed to determine appropriate
treatment and management measures.
However, there is no simple on-farm evalu-
ation system to characterise disease sever-
ity that relates accurately to the outcome of
the disease. For example, bacteraemia was
never observed in field cases by Powers
et al. [189] whereas Cebra et al. [42] reported
bacteraemia in 1/3 of the cows that were
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suffering from severe clinical mastitis.
Wenz et al. [253] isolated bacteria from the
blood of some cows that were scored as
“mild reaction”.
5.2. Scoring severity under field 
conditions
Despite appreciable efforts to introduce
clear definitions and scoring for mild, mod-
erate and severe based on systemic signs
[253], there is still some confusion in the
field. In the field, oversimplifying the term
mastitis may lead to wrong interpretation
of the terms mild, moderate and severe.
The terms mild and moderate are some-
times (mis)used to describe the local symp-
toms; e.g. mild is often used to describe
appearance of clots or flakes in the milk
with little or no signs of swelling of the
mammary gland. In the field this is usually
associated with infections by minor patho-
gens [128] such as coagulase negative Sta-
phylococci (CNS) and Corynebacterium
bovis. Moderate and severe are often used
to refer to visibly abnormal milk accompa-
nied by swelling in the affected mammary
quarter. Generally, a correlation exists
between the local clinical signs and the
severity of systemic symptoms. However,
discrepancies have been noticed, especially
during the onset of severe E. coli mastitis
around parturition where slow progressing
and less visible local swelling is clinically
misleading because this mild local reaction
will be rapidly succeeded by severe symp-
toms of shock [93, 95, 245]. The dilemma
for farmers and veterinarians is that the
lack of inflammation and clinical symp-
toms in the udder often makes rapid diag-
nosis difficult. By the time a diagnosis can
be made, it is too late to save the animal. On
the other hand, during mid and late lacta-
tion the local symptoms of the disease may
be so short lived and mild, that it is difficult
for a milker to recognise this self-curing
condition [97]. It is clear that under field
conditions there is a need for exact ranking
of severity through application of clear
and generally accepted definitions. Mis-
classification through misuse or use of
less specific definitions may lead to dubi-
ous conclusions. Agreement on definitions
would also be in favour of comparing field
and experimental studies. The terms mild,
moderate and severe that are used by Wenz
et al. [253] under field conditions are only
based on systemic parameters such as rec-
tal temperature, hydration status, rumen
contractility and attitude of the animal. The
principle to relate severity to systemic
factors is in agreement with the severity
classification used under experimental
conditions (e.g. [31, 59, 93, 98, 124–126,
210, 242, 245]). 
5.3. Experimental  severity 
classification
Studies of Hill et al. [95] with E. coli
mastitis demonstrated that those animals
which displayed a pronounced local acute
inflammatory reaction showed fewer sys-
temic symptoms than those that did not.
Occasionally, and only during early lacta-
tion, bacterial multiplication in the mam-
mary gland induces only a very slow acute
phase response. The progress made by the
invading pathogen is so fast, or the acute
inflammatory reaction by the host so slow,
that the cows show very grave systemic
signs because of the lack in local control
of the pathogen. This clinical type of mas-
titis was defined by Schalm et al. [203] as
a peracute mastitis and corresponds with
the severe responders in the study of
Vandeputte-Van Messom et al. [245]. Over
the years, several attempts have been made
to estimate severity under experimental
conditions. It was suggested by Heyneman
et al. [93] to distinguish between moderate
and severe responders during early lacta-
tion. Although this method has been shown
to be useful at many occasions, one of
the problems is that in some cases the
severity response is very gradual, espe-
cially if the whole lactation period is con-
sidered. In this case severity classification
as proposed by Hirvonen et al. [98] into
mild, moderate and severe responders is
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preferred. Parameters that can be used to
estimate severity under experimental con-
ditions can be divided into local and sys-
temic disease parameters. 
5.4. Local disease parameters
Fast and uncontrolled growth of I.M.
E. coli with large numbers of bacteria in the
udder cistern can occur. This is especially
related with the period of parturition and
early lactation [26, 41, 59, 79, 93, 97, 125,
126, 145, 167, 210, 241, 244, 245] and this
explosive growth of I.M. E. coli  is less
apparent during established lactation [16,
97, 98, 102, 195, 210]. Also older cows
exhibit higher cfu during coliform mastitis
[190, 241]. In these studies the number of
bacteria that grow in the gland cistern (esti-
mated as cfu) is linked to the severity of col-
iform mastitis. Cows in the severe group
have significantly more bacteria in the
gland cistern than cows in the moderate
groups. Under experimental conditions this
can be quantified by measuring the area
under the curve (AUC) of bacterial growth.
AUC has been successfully used in many
experimental studies [59, 125, 126, 145,
241, 242]. LPS may increase dramatically
at sites of bacterial replication especially
during fast and uncontrolled growth of
E. coli in the udder cistern. Although meth-
ods have been developed to measure the
LPS content of milk [92, 258, 261] no
attempt has been made to estimate severity
on basis of the endotoxin dosage in the
udder cistern. A good severity indicator
may be TNF- in milk, because of its typ-
ical release during acute E. coli mastitis and
not during S. aureus mastitis [195]. Gener-
ally, most studies indicate that the amount
of TNF- that is released in milk is closely
associated with peracute signs of coliform
mastitis [98, 210, 211, 219] but practically
no difference in local TNF- response was
found between E. coli and LPS mastitis [16,
102]. Exact quantification of the expression
of mRNA for TNF- in cells derived from
infected mammary glands through reverse
transcription polymerase chain reaction
might be helpful in the future. 
During a balanced I.M. inflammatory
reaction, bacterial growth will be under
control and only a few bacterial cfu will
develop in the udder cistern of the cow. Low
levels of LPS will be released leading to
moderate and specific cytokine pattern pro-
duction by the macrophages which will
promote optimal body innate defence
mechanisms and minimal systemic signs
such as fever and leukopenia. Animals
reacting in this way were called moderate
responders [245]. They typically show a
steep increase in SCC, due to fast migrating
neutrophils that inhibit bacterial growth
effectively. There is experimental evidence
that these neutrophils might also destroy the
endotoxin in the mammary gland [60].
Slow neutrophil influx is observed in severe
responders (see Fig. 2, [245]) and they
might start releasing their proteases and
ROS in the mammary tissue before reach-
ing the pathogens. For some reason, neu-
trophils are stacked in the tissue. However,
this phenomenon could not be confirmed by
Shuster et al. [210]. As E. coli population
can double every 20 min, a delay of just
20 min in neutrophil arrival in lacteal secre-
tions has a significant effect. A 1-h delay in
neutrophil recruitment into the mammary
gland could result in an 8-fold larger
number of E. coli to kill and that much more
endotoxin to detoxify [119]. 
In a recent study, in vitro growth of
E. coli in milk was studied to explore the
hypothesis that milk from individual cows
differs in its growth medium properties for
E. coli, and whether possible variation
could be related to specific milk constitu-
ents. The growth differed substantially
between individual cows within an incuba-
tion period comparable with the early
phase of I.M. infection, suggesting that the
growth medium properties of milk could be
of importance in the pathogenesis of E. coli
mastitis and subsequent outcome of disease
[123].
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5.5. Systemic disease parameters
During experimental studies, differ-
ences in the fever response were observed
that were related to severity [102, 210,
245]. Under field conditions, rectal tem-
perature is one of the disease parameters
used to classify severity [253]. Careful
interpretation of local TNF- release is
needed because it is known that at low
doses, TNF- has a protective role during
invasive infections so that increase in
TNF- may be a normal response to bacte-
rial invasion. For example, although prac-
tically no difference in local TNF-
response was found between the E. coli
and LPS mastitis model, the increase in
plasma TNF- peaked highest after I.M.
E. coli infection [16, 102]. TNF- might
have been absorbed from the E. coli
infected udder and/or secreted from acti-
vated mononuclear cells such as mono-
cytes and macrophages in the body [102].
The subsequent grave systemic signs may
be due to abnormal regulation of a normal
TNF--mediated response. The decreased
rumen motility that has been observed dur-
ing coliform mastitis under both experi-
mental [102, 143, 245] and field conditions
[253] may be related to the increase of
TNF- in the blood plasma. The pivotal
role of TNF- in this host reaction is sug-
gested by four lines of evidence: (1) the
decrease in rumen motility is not observed
or at least very mild during experimentally
induced endotoxin mastitis [102, 143];
(2) TNF- is one of the earliest mediators
secreted by the host in response to I.M.
E. coli infection [195]; (3) TNF- in blood
plasma is higher after I.M. E. coli infection
than during endotoxin mastitis [102] and
(4) administration of TNF- to goats elic-
its inhibition of rumen contractions [240].
One of the criteria used by Wenz et al.
[253] under field conditions is rumen con-
tractility. Clinical mastitis induces a non-
specific acute phase response (APR) and
the initiation of APR is also thought to be
caused by the production of TNF- [102].
Changes in plasma haptoglobin occurred
sooner in endotoxin mastitis than during
E. coli mastitis. However, the total response
was practically  similar in both models
[102]. These observations are in accord-
ance with the findings in the study of
Hirvonen et al. [98] where serum hap-
toglobin did not correlate with the severity
of the disease. Serum amyloid-A (SAA,
another acute phase protein) rose gradually
in the severely affected cows, and signifi-
cant differences were found between
severely vs. moderately or mildly affected
cows at day 4. Serum TNF- concentra-
tions only increased in the severely affected
cows. During severe clinical coliform mas-
titis a decrease in total milk yield occurs. It
Figure 2. Multiplication rate of E. coli (106/mL; ) in inoculated mammary glands and pattern
of leukocyte influx (105/mL; ) into milk in (a) periparturient moderate responders compared
with (b) those in severe responders during experimentally induced E. coli mastitis. (Figure taken
from the original paper [245], with permission.)
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is not surprising that milk production was
also reduced in uninfected quarters during
coliform mastitis [59, 93, 99, 100, 102,
152, 167, 210, 245]. The magnitude of this
reduction is the result of: (1) a local effect
induced by the invading pathogen and in
which inhibition of milk synthesis and
tissue damage is involved, and (2) the
degree of systemic disease; e.g. decrease
in gastro-intestinal motility and subse-
quent reduction in availability of milk pre-
cursors [30, 93, 143, 144]. The loss in milk
production in the uninfected contralateral
quarters on day 2 after infection, has been
used as a criterion to classify cows as mod-
erate or severe responders to experimental
E. coli mastitis after parturition [93, 245].
Milk production losses in uninflamed
quarters are negligible in endotoxin masti-
tis but substantial during E. coli mastitis,
probably due to pronounced systemic
effects [102]. Harmful effects are first seen
systemically, due to excessive release of
cytokines. The animals are depressed, have
ruminal stasis and diarrhoea, cardiovascu-
lar collapse resulting in shock and multiple
system organ failures which in its most
extreme form may lead to death [97]. The
infected gland shows extensive tissue
destruction [97] and decrease in milk
secretion [152]. In the uninfected glands
milk production is depressed for several
days [93, 245].
5.6. Is severity predictable?
Severity classification and prediction
under experimental conditions have received
a lot of attention over the past 15 years,
especially in connection with treatment
regimens where sham treated animals are
compared with specific drug treated ani-
mals (e.g. [244]). Nowadays we know that
several host determinants influence the sen-
sitivity for coliform mastitis, i.e. stage of
lactation, number and function of periph-
eral PMN, SCC, age of the host, genetic
resistance, nutritional status, other peripar-
turient diseases, and the vaccination status
[180]. The variability in severity to E. coli
mastitis during early lactation can be so
large that extremely high numbers of ani-
mals per group have to be included in the
study. Several prediction markers have
been tested in relation to severity of E. coli
mastitis under experimental conditions,
among them: total number of circulatory
leukocytes and PMN (see Tab. I; [93]), the
oxidative burst of PMN (see Tab. I), PMN
chemotaxis and neutrophil alkaline phos-
phatase (NAP, E.C. 3.1.3.1). The number of
circulating peripheral leukocytes just
before bacterial inoculation also predicted
the severity estimated by the AUC of bac-
terial counts and residual milk production
(reviewed by [33]). Variation in severity
could not be explained by pre-infection
Table I. Correlations between the phorbol myr-
istate acetate (PMA) and zymosan induced res-
piratory burst of bovine neutrophils expressed as
 generation/cell (nmoles /cell) and 
 generation capacity (nmol   neutrophil
number) prior to the inoculation of Escherichia
coli and the severity of mastitis1. (Table taken






Neutrophil number –0.58* –0.48*
PMA - induced 
 generation / cell –0.16 –0.22
H2O2 generation / cell –0.18 –0.26
Zymosan - induced
 generation / cell –0.80** –0.67*
PMA - induced
 generation capacity –0.77* –0.72**
Zymosan - induced
 generation capacity –0.90*** –0.75**
1 Severity of mastitis was estimated as the percen-
tage decrease in milk and -lactalbumin production 
on day +1 and +2 after inoculation of E. coli into the 
udder.
2 Correlation coefficients with probabilities *P 
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NAP levels. Of the pre-infection tests for
leukocyte function, chemotaxis of PMN
isolated from the peripheral blood at
day –2 and –1, and immediately prior to
infection best predicted the outcome of the
induced E. coli mastitis [125]. Predictions
were most significant within 24 h before
challenge (see Tab. I). Predictive signifi-
cance was rapidly lost when samples were
taken earlier (from day –2 to –6, [125]). It
was concluded that PMN functions could
not be used to predict severity over longer
periods, probably due to the short half-life
of these cells. On the other hand, very short
significant predictions can be made (within
two days) which may be useful for some
experimental purposes. 
5.7. Modulation of severity
Activation of innate immune responses
by LPS can be inhibited by various soluble
molecules that bind LPS and neutralise its
activity. However, LPS is not a classic vir-
ulence factor but it contributes to the patho-
genic potential of Gram-negative bacteria
by activation of host defensive systems
which ultimately results in both, clinical
signs and tissue damage. The pro-inflam-
matory nature of LPS plays a critical role
in the successful elimination of the infect-
ing pathogen [75]. Furthermore, in many
LPS-models the effect on several biologi-
cal systems seems to be dependent on the
dose [151]. Therefore, modulation rather
than complete inhibition of the action of
the LPS molecule is preferable. 
Modulation of inflammation and tissue
damage in coliform mastitis can be obtained
through antibodies directed against the cell
wall [65] or through LPS scavengers such
as polymyxin B [262]. Nowadays, the tools,
techniques and products to study and modu-
late host-pathogen interactions are made
available by advances in molecular biol-
ogy. The cloning and expression of proteins
such as recombinant bovine soluble (rbos)
CD14, may provide ways of minimising
damaging effects of LPS during acute coli-
form mastitis. CD14 binds and neutralises
LPS and causes local recruitment of neu-
trophil after binding of CD14-LPS com-
plexes to mammary epithelial cells [180]. 
6. LIFESPAN OF PMN:
FROM MATURATION 
TO SENESCENCE
6.1. Proliferation, differentiation 
and maturation of PMN
During postnatal life hematopoiesis is
restricted to the bone marrow, whereas the
liver and the spleen are inactive but retain
their hematopoietic potential. All blood
and immune cells originate from a self-
renewing small population of pluripotent
stem cells (CFU-S) that can replicate them-
selves, or can become committed to a par-
ticular development pathway. PMN are
formed through the multi-step process of
granulopoiesis, from the colony-forming
unit of granulocytes (CFU-G) through
myeloblasts, promyelocytes, myelocytes,
metamyelocytes, and band cells. Precursor
cells undergo striking morphologic, bio-
chemical and functional changes during
granulocytic maturation. These changes
are associated with significant changes
in cell size and nuclear shape, and with
the development of stage-specific proteins
essential for phagocytosis and bacterial
killing. Glasser and Fiederlein [83] pro-
vided knowledge about the acquisition
sequence of functional properties during
human granulopoiesis. Data were frequently
extrapolated to the bovine species, although
species variation in neutrophil function has
been clearly demonstrated [225]. Because
alterations in the granulopoiesis may under-
lie the significant changes in the function,
number and maturity of circulating PMN
observed during coliform mastitis, atten-
tion was drawn to the niche of these cells in
the bovine. A prerequisite for studies on
the maturity of cells is a reliable separation
method, in order to obtain enriched cell
fractions of different maturation stages.
Recently, Van Merris et al. [238] developed
Severity of E. coli mastitis in dairy cows 539
a discontinuous Percoll gradient on which
centrifugation of bone marrow resulted in
three maturation-dependent cellular frac-
tions. In a subsequent study, the functional
maturation sequence during bovine granu-
lopoiesis was established and proposed to
be the following: myeloperoxidase activity
– Fc-IgG2 receptor expression – CD11b
expression – L-selectin – phagocytosis –
respiratory burst activity (Fig. 3) [239]. In
analogy to human hematopoiesis [83], the
acquisition of various biochemical and
functional properties in bovine PMN was
found to take place in different stages of
maturation in the bone marrow. The effi-
ciency of PMN against invasion of the
mammary gland was previously shown to
be highly dependent on the rate of diaped-
esis into  the infection site [95] and on the
ability of these PMN to generate ROS [93].
Although the immature cells expressed
already the membrane adhesion molecule
CD11b, they were not capable to rapidly
migrate to the infected mammary gland,
and ingest and kill efficiently the invading
bacteria. The limited chemotactic and
phagocytic ability in immature cells could
be due to membrane rigidity with poor cel-
lular deformability, in association with a
large nucleus [141]. The incapacity to pro-
duce ROS was attributed to the absence of
membrane-bound NADPH-oxidase activity,
as myeloperoxidase was already present in
the rare azurophilic granules at the promy-
elocytic stage [239]. These findings were
in general agreement with previous obser-
vations of Silva et al. [212]. Thus, when
maturation is impaired due to an increased
proliferation rate, a higher number of
immature cells will appear in the circula-
tion. These findings support the hypothesis
postulated by Guidry and Paape [88],
namely that the presence of myelocytes,
metamyelocytes and band cells (left-shift)
observed during acute coliform mastitis in
early lactation may compromise the cows’
resistance by supplying more cells that are
morphologically immature and function-
ally inadequate.
Alkaline phosphatase is present in sub-
stantial amounts in the cytoplasm of PMN
[248]. In human, NAP activity fluctuates in
a variety of physiological (pregnancy,
stress) and pathological conditions (mono-
nucleosis, myeloproliferative disorders)
(summarised in [174]). Conflicting data
Figure 3. Stepwise acquisition of functional properties in bovine bone marrow cells during
granulopoiesis. (Figure adapted from the original paper [239], with permission.)
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resulted in an unclear and still controversial
relationship between cell maturity and NAP
activity. Some authors observed the NAP
activity mostly in functionally and chrono-
logically older neutrophils [17, 118]; others
assessed highest NAP in immature cells
[120, 256]. The latter indicated that eleva-
tion of NAP activity of circulating PMN
may coincide with the increased release of
precursor cells from the bone marrow. A
significant increase in NAP activity was
observed during experimental E. coli mas-
titis [94]. Van Werven et al. [242] demon-
strated that the increase was a result of
increased enzyme activity per neutrophil,
rather than an increase of the number of
neutrophils exhibiting NAP activity. The
NAP-inducing factor was shown to be iden-
tical to G-CSF [200], the growth factor thus
being responsible for starting the synthesis
of the enzyme in the neutrophil. Therefore,
the enhanced NAP activity after onset of
mastitis was believed to be induced by
G-CSF, reflecting an increased prolifera-
tion and differentiation of bone marrow
granulocytes [94]. 
It has been postulated that cells leave
the bone marrow more-or-less by a pipe-
line mechanism, the older cells being
released first [149]. The mechanisms that
control the release of mature PMN from
the bone marrow into the circulating pool
are poorly understood. Anatomical locali-
sation of the hematopoietic cells close to
vascular spaces, and the development of
transient holes in the venous sinuses to
allow egress of marrow cells have been
suggested as mechanism. Also the develop-
mental changes in the nucleus and the cyto-
plasm of the maturing cells that increase
their motility, deformability, and chemo-
tactic ability could attribute to the release
of terminally differentiated PMN from the
hematopoietic compartment into the effer-
ent vascular space [140]. Van Eeden et al.
[236] assigned a possible role to L-selectin
in the release of PMN from the bone mar-
row in human, as L-selectin was highly
expressed on mature PMN in the post-
mitotic pool in the bone marrow [231].
With active bone marrow release there was
an increase in the number of PMN express-
ing high levels of L-selectin in the circula-
tion [236]. However, levels of L-selectin
on circulating PMN never reached levels
expressed in the bone marrow, suggesting
that L-selectin is shed as PMN enter the
circulation. Recently, Monfardini et al.
[168] provided evidence for a maturation-
dependent increase in L-selectin expres-
sion during granulopoiesis in the bovine.
The findings were consistent with previous
reports in human that a high number of cir-
culating bovine PMN expresses CD62L
but at a lower level than mature bone mar-
row granulocytes. PMN can shed L-selectin
from their surface as a part of a de-adhe-
sive event during recruitment into a site of
inflammation [46]. The loss of  L-selectin
when crossing the endothelial barrier in the
bone marrow upon release into the blood
stream could be a similar process. Alterna-
tively, high levels of L-selectin on mature
PMN might keep them attached to the
endothelium of the bone marrow sinu-
soids, and stimuli for release may activate
the proteolytic cleavage of L-selectin [236].
6.2. Regulation of the granulopoiesis
The process of granulopoiesis is strictly
controlled by regulatory growth factors,
comprising cytokines and colony-stimulat-
ing factors (CSF), to ensure the mainte-
nance of a steady state. The hematopoietic
growth factors have pleiotropic effects on
proliferation, differentiation and functional
activation of precursor cells [164]. They
interact at various levels of the differentia-
tion cascade, from unipotent stem cell to
mature PMN. The biologic effects of the
growth factors are mediated through spe-
cific receptors on the surfaces of target pro-
genitor cells. 
Hoeben et al. [101] investigated the
effect of hormones and metabolites, of
which the concentration changes substan-
tially around parturition in the bovine.
Using an optimised cell culture assay for the
bovine [237], it was demonstrated that
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-hydroxybutyric acid (BHBA) and ace-
toacetic acid (AcAc) induced significant
inhibitory effects on the proliferation of
hematopoietic cells at concentrations
observed after parturition. In a study of Van
Werven et al. [243] a high pre-infection
BHBA concentration was strongly nega-
tively correlated with the pre-infection
number of circulating PMN. Bovine preg-
nancy-associated glycoprotein (bPAG) also
reduced the proliferative activity of bovine
progenitor cells. Hydrocortisone-21-ace-
tate (HCAc) inhibited the hematopoietic
activity of bovine bone marrow at concen-
trations of 10 to 100 ng/mL [101]. At
calving, a short lasting cortisol peak of
approximately 20 ng/mL is observed,
whereas during mastitis increases up to
100 ng/mL are possible [215]. The inhibi-
tory effects of BHBA, AcAc, bPAG, and
HCAc may be involved in the changes in
the number, differentiation and maturity of
circulating PMN after calving [101], as the
circulating pool is largely depending on the
proliferative capacity of the bone marrow. 
The action of growth factors, inflamma-
tory mediators, metabolites and hormones
on the proliferation, differentiation, and
function of PMN is provided in Figure 4.
6.3. Ageing of PMN
After having exerted their role in
immune function PMN die by senescence
[255]. Aged PMN undergo spontaneous
apoptosis in the absence of pro-inflamma-
tory agents prior to their removal by mac-
rophages [201], thus preventing the release
of their cytotoxic content. One of the dom-
inant theories of senescence, the soma the-
ory [122], suggested that replicative cells
accumulate genetic damage, resulting in
functional decline. Arguing against this
proposal in the case of ageing of PMN, were
the findings of Chatta et al. [45] and Born
et al. [18] indicating that the proliferative
and differentiation capacity of hematopoi-
etic progenitor cells was largely unaffected
by ageing in humans. However, the ability
of progenitors to proliferate and differenti-
ate in response to hematopoietic factors
does not necessarily guarantee that the
resulting PMN are competent [35]. Inflam-
mation and infection do increase the rate of
PMN production, shortening the matura-
tion time and leading to the release of
immature immune cells in the circulation.
Schalm and Lasmanis [204] reported that
during mastitis the myeloid/erythroid ratio
in bovine bone marrow increased above
1.0, reflecting an intensified granulopoie-
sis, probably to ensure replenishment of the
PMN reserve and the return to homeostasis.
7. HOST FACTORS THAT 
INFLUENCE SEVERITY
7.1. Stage of lactation
Defense of the bovine mammary gland
is continually challenged by environmen-
tal exposure to bacteria, and many factors
affect the outcome of this challenge. On
average 1% of mammary quarters in the
dairy cow population will have I.M. infec-
tion with Gram-negative bacteria com-
pared to an infection rate of 35–50% for
Gram-positive bacteria [68]. The rate of
clinical mastitis during the first 2, 4, and
8 weeks after parturition increases from
25%, to over 45% and to 60%, respectively
[109]. A high percentage of I.M. infections
present at parturition also develop into
clinical mastitis during the first 60 to
70 days of lactation [104]. The early post-
partum period is a period of high risk for
severe clinical mastitis because of extreme
sensitivity for a number of animals for I.M.
infection with ordinary environmental bac-
teria such as coliforms [93, 124, 125, 245].
Severe clinical mastitis with grave sys-
temic symptoms typically occurs around
parturition and during early lactation. Coli-
form mastitis after peak lactation is a mod-
erate and self-curing disease. In some
cases (during mid and late lactation) the
symptoms of the disease are so mild and so
short lasting, that it is difficult for a milker
to recognise this self-curing condition
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[97]. Today, we know that severity of
bovine E. coli mastitis is mainly deter-
mined by cow factors rather than by the
pathogenicity of the invading pathogen.
For example, it is well recognised that the
bovine immune system is less capable of
battling pathogens during the peripartu-
rient period and early lactation. Although
exact causes for a compromised immune




      
        
      
Figure 4. Action of growth factors, inflammatory mediators, metabolites and hormones on the pro-
liferation, differentiation, and function of PMN in the bovine. CFU-S, colony-forming units spleen;
CFU-GEMM, colony-forming units of granulocyte, erythrocyte, monocyte and megakaryocyte;
CFU-GM, colony-forming units granulocyte and monocyte; SCF, stem cell factor; GM-CSF, granulo-
cyte-macrophage colony-stimulating factor; G-CSF, granulocyte colony-stimulating factor; BHBA,
-hydroxybutyric acid; AcAc, acetoacetic acid; bPAG, bovine pregnancy-associated glycoprotein;
IL, interleukin; RA, retinoic acid; Adr, adrenaline; GCS, glucocorticosteroid.
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believed to be at least influenced by hor-
monal and metabolic changes associated
with pregnancy, parturition, and onset of
lactation [57, 61, 62, 87, 126, 147, 148,
162, 185, 226].
7.2. Number and function of circulating 
PMN
The PMN population represents a major
line of defence against infection in the
bovine mammary gland. Indeed, the speed
of PMN influx into the udder tissue can
determine the severity of the mastitis [96,
245]. However, during the periparturient
period the number and the different func-
tions of circulating PMN, such as diapede-
sis, phagocytosis, and bacterial killing are
altered [31, 57]. Major variations in PMN
number and function occur within a fairly
small period of about one week after partu-
rition (Fig. 5). Interestingly, studies per-
formed during early lactation (up to two
months after parturition), indicate that the
number of circulating PMN correlates with
the severity of Gram-negative mastitis [93,
126, 243, 245]. Different characteristics of
peripheral PMN, such as stimulated CL
activity, cytochrome c reduction, chemo-
taxis, and stimulated L-selectin and CD11b
expression, have also been related to the
severity. In addition, other pre-infection
metabolic parameters in blood, such as
-hydroxybutyric acid, non-sterified fatty
acids, glucose, Mg2+, Ca2+, cortisol, and
cholesterol concentration, as well as in
milk, such as SCC, albumin, fat, and casein
production, have also been found to be
associated with the severity of E. coli-
induced mastitis [52, 59, 93, 116, 121, 126,
210, 245, 259]. Other studies have com-
pared the functionality of PMN between
early and later stages of lactation [158–
160]. The basal adhesion molecule levels of
CD62L and CD18 at the surface of circu-
lating PMN and the phagocytic activity of
blood and milk PMN have been described
to be similar during early lactation as com-
pared to later stages of lactation [63, 210].
Interestingly, ROS production and killing
activity of blood and milk PMN were sig-
nificantly decreased in early lactation [63,
158, 159, 161]. Because PMN functions are
markedly altered around parturition (Fig. 5),
detailed studies have been done during the
last years in our laboratory. CL of stimu-
lated blood and milk PMN was lower dur-
ing early lactation as compared to mid or
late lactation. Moreover, the ratio of stimu-
lated milk to blood PMN CL was lower
immediately after calving [158]. The low
responsiveness of milk PMN towards PMA
during early lactation could have resulted
from a weaker stimulation of protein kinase
C and NADPH-oxidase [117]. In addition,
differences were observed in the kinetics of
the PMN CL curve. Luminol-enhanced
blood PMN CL kinetics showed a biphasic
course during mid and late lactation. How-
ever, within the first ten days after parturi-
tion, only the immediate first peak was
observed. CL in milk PMN was always
monophasic with minimal intensity and
durability during early lactation [158]. The
luminol-dependent CL system requires
H2O2 [73, 142] and both intra- and extra-
cellular events contribute to this CL [69]. It
is likely that the intracellular H2O2 produc-
tion and MPO-H2O2-halide activity is
higher in blood than in milk PMN and their
impairment is maximal during early lacta-
tion (Fig. 6; [158]). The decrease in ROS
production in early lactating cows seems to
be related with the diminished viability of
milk-resident PMN detected in this period.
7.3. SCC and age of the host
There is evidence to suggest that minor
pathogens increase milk cell counts and
can help to protect the udder against masti-
tis [128]. In addition, herds with low SCC
have a higher incidence of environmental
mastitis compared to herds with high SCC
[85, 205, 227, 247]. However, the correla-
tion between SCC in the milk and the
immune response of the udder to infection
is not clear. Indeed, mastitis incidence and
SCC levels are both higher in older cows.
This paradoxical finding could be well
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Figure 5. Schematic illustration showing major dynamic changes in circulating PMN numbers and
functions around parturition and during coliform mastitis. The thickness of the curves reflects the
degree of observed experimental variability with respect to a given parameter. The increase of
catecholamines (dashed lines) and glucocorticoids (dotted lines) levels in blood occurs
concomitantly with calving or shortly after coliform mastitis. (Figure taken from the original paper
[57], with permission.)
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related to the functionality of the resident
milk cells. Indeed, milk PMN in primipa-
rous cows have been found to have a
higher viability and ROS production as
compared to older animals [161]. There-
fore, primiparous and older high-yielding
cows should be evaluated in different cate-
gories.
7.4. Nutritional and metabolic status
The peripartum period represents a
period of significant decrease in energy,
protein, and trace element concentrations
in blood that may influence the outcome
of the disease. Vitamin E and Se are
essential nutrients that share common bio-
logical activities. Deficiencies in either of
these micronutrients have been related in
increased incidence and severity of masti-
tis. They are integral components of the
antioxidant defence of tissues and cells
[105, 214]. Elevated plasma concentration
of ketone bodies in blood, due to the enor-
mous increase in demand for energy by the
onset on lactation at calving, has also a
negative effect on PMN function and is
associated with susceptibility to mastitis
[226].
7.5. Genetic resistance
Several significant genetic associations
have been found between the severity of the
mastitis and several parameters, such as the
number and different functions of circulat-
ing PMN in early lactation, the serum con-
centration of Ig, and the SCC. For details we
refer to specialised reviews [51, 180].
8. INFLAMMATORY PARAMETERS 
AND SEVERITY
8.1. Local signs
Udder abnormalities (increased firm-
ness, swelling, watery milk with clots or
flakes) are often a first indication of masti-
tis. However, these udder and milk changes
do not predict the overall severity of the
disease. The severity of E. coli mastitis has
been directly related to the level of bacte-
rial counts in milk [59, 98, 145, 210, 245]
and the loss of milk production, especially
in the non-infected quarters [59, 93, 245].
8.2. Circulating leukocytes
PMN in blood and milk are important
components of the mammary gland defence
against coliforms [31]. Number and func-
tion of bovine PMN respond differently to
E. coli experimental infection depending
on the severity of the mastitis. It is likely
that the more severe disease course of
E. coli mastitis during early lactation is due
to a delay in mobilisation rate of PMN into
the udder [96, 210, 245] and a reduced
capacity of PMN to generate ROS [93],
Figure 6. Viability of milk and blood
PMN during early, mid and late lactation
in dairy cows. Values are means  SEM
of 10 cows. (Figure taken from the
original paper [158], with permission.)
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resulting in failure to eliminate the bacteria
from the infected quarters. The efficient
migration of circulating PMN to the mam-
mary gland depends on the correct expres-
sion and activation of several adhesion
molecules. Bovine leukocyte adhesion
molecules such as L-selectin (CD62L) and
2-integrins play a key role in the initial
contact and in the subsequent strong adhe-
sion to the vessel endothelium, respectively
[56, 218]. Interestingly, in high-yielding
cows infected with E. coli during early lac-
tation, a higher increase of CD11b expres-
sion and a more pronounced decrease of
CD11a and CD62L levels have been
reported in severely diseased animals [55,
59]. These molecules are known to be indi-
cators for the activation status of the cells.
Therefore, the difference in expression
level is probably related to the presence of
bacteria in milk for a longer period in
severely affected cows, which in turn
release LPS and thereby extend the period
of the activation status of blood PMN.
During the first stages of experimental
mastitis, the chemotactic response of leu-
kocytes decreased in both, moderately and
severely infected animals. The recovery of
the chemotactic response of the leukocytes
occurred more rapidly in moderately than
in severely diseased cows [124]. It has been
observed that early after challenge phago-
cytosis decreases in circulating PMN, but
the initial decrease occurred faster in
severely affected cows. From day 6 on
after challenge, values increased over pre-
infection levels and remained higher in
severely affected animals [59]. Heyneman
et al. [93] found a correlation between
ROS production during the inflammatory
response and the severity of mastitis.
In moderately affected cows, the initial
neutropenia was followed by a return to
basal levels after 2 to 3 days. However, one
week after infection severely diseased ani-
mals developed a neutrophilia during
which metamyelocytes and myelocytes
appeared frequently in the blood, and even
became the predominant leukocyte types
[94]. Possibly, the larger proportion of
immature PMN partially accounts for the
lower chemotactic response of the circulat-
ing PMN during experimental mastitis in
the severely diseased cows [125, 245].
Neutrophil alkaline phosphatase activity
was significantly higher in severe cases of
mastitis during the 2nd week after inocula-
tion. Basal NAP activity was regained after
about two weeks in moderately diseased
animals but lasted for several weeks in
severely affected cows [94, 242]. The
severity of the infection has been correlated
with lower plasma Zn and Fe concentra-
tions during the acute phase [145]. In addi-
tion, in severe mastitis highly persistent
levels of cortisol were measured as com-
pared with mild or moderate situations [98].
It seems that circulating PMN of
severely diseased animals are in a status of
increased activation for a longer period
of time than moderately affected cows.
Indeed, it has been observed that the clini-
cal condition of severe cases only starts to
deteriorate after one or two days post-
infection, which is much later that the onset
of clinical mastitis [98]. This idea is in
agreement with the concept that severity of
coliform mastitis can be estimated on basis
of the milk loss in the uninfected quarters,
48 hours after infection [59, 93, 125, 244,
245].
8.3. PMN viability
A crucial aspect of mammary gland non
specific defence status is milk PMN viabil-
ity, which is influenced by (patho)physio-
logical conditions of the gland [157, 158,
161, 187]. Apoptotic PMN are removed
through phagocytosis by macrophages.
Necrotic cells are not promptly cleared by
phagocytes and their chromatin proteins
may boost prolonged inflammation [202].
A low viability of resident milk PMN is
observed during early lactation and this
may compromise the total phagocytic and
bacteriostatic capacity of the teat cistern.
This could facilitate the growth of E. coli,
especially during their lag phase. How-
ever, it is far more efficient to clear the
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bacteria from the teat cistern with newly
attracted viable PMN that engulf and kill
the bacteria effectively. The increased milk
PMN viability during LPS and E. coli mas-
titis that has been observed recently [157,
160] can be considered as a physiological
homeostatic mechanism that could prevent
inappropriate and prolonged inflamma-
tion. Mammary tissue damage may also be
more important if viability is not optimal
during E. coli mastitis. It is conceivable
that milk PMN viability contributes to
the pathophysiology and the outcome of
E. coli mastitis.
9. TISSUE DAMAGE 
AND PRODUCTION LOSS 
DURING E. COLI MASTITIS
9.1. Pathologic findings during E. coli 
mastitis
General pathology books describe
necrosis of the mammary epithelium dur-
ing severe, naturally occurring clinical
coliform mastitis [113]. Epithelial lesions
appear very rapidly in experimental models
where E. coli is infused I.M. with variable
doses (200 to 109 cfu). Frost et al. [77]
showed that after I.M. infection (approxi-
mately 109 cfu) E. coli multiplied very rap-
idly in the teat sinus, lactiferous sinus and
large ducts. Within one hour, epithelial
lesions were seen on these places, espe-
cially in the teat sinus. After two hours epi-
thelial lesions were extensive and there was
microscopical evidence of inflammation.
However, lesions never went beyond the
basal membrane. At four hours post-infec-
tion, inflammation was seen in the ducts
and secretory tissue and there was massive
infiltration of the lesions with PMN. Espe-
cially in moderate cases, there was a mini-
mum of alveolar involvement. The same
sequence of events was observed when
smaller numbers of pathogens were infused
I.M. [26]. In very severe cases of coliform
mastitis there is a limited inflammatory
reaction with an extensive involvement of
the secretory tissue. A rapidly ascending
infection, spreading via the ductular sys-
tem, was observed [79]. In its most severe
form, with totally uncontrolled bacterial
multiplication and all lactiferous sinus epi-
thelia lost, interstitial tissue became totally
haemorrhagic and the animal died of toxae-
mia within a few hours of infection [97]. In
the early stages of experimentally induced
E. coli mastitis, when lesions develop in the
epithelium of the teat and lactiferous
sinuses, neutrophils are in the subepithelial
tissue. They first appear as mounds over the
lesions but finally move through these
lesions into the lumen of the gland into the
milk [97]. Experimentally induced E. coli
mastitis also promotes apoptosis and cell
proliferation. During the later stages of
moderate E. coli mastitis, apoptosis has
been observed in the mastitic tissue.
Expression of Bcl-2 associated x protein
(Bax, a proapoptotic protein) and IL-1
converting enzyme increased in the tissue
at 24 h and 72 h post-infection. At 24 h
Bcl-2 expression decreased. Induction of
matrix metalloproteinase-9, stromelysin-1
and urokinase-type plasminogen activator
was also observed in the mastitic tissue.
Next to this, cell proliferation was also
increased in the inflamed mammary gland
[146].
9.2. Tissue damage and milk loss 
vs. high SCC
I.M. infection is the primary reason for
increased SCC for all types of mastitis. A
negative correlation exists between SCC
and milk yield [50, 192], indicating that a
great part of the mammary epithelium may
be damaged by the invading bacteria and/
or the phagocytes that were sent out by the
defence system of the host. Decreased or
lost milk production is an important aspect
of clinical mastitis. High-producing cows
might never achieve the total lactational
output that would have been expected. Per-
manent blunting of milk production may
also occur for the remainder of that lacta-
tion. This effect is very damaging when
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mastitis occurs before the cow reaches its
peak lactation. Phagocytes, and more espe-
cially neutrophils, are necessary to elimi-
nate the invading bacteria. PMN migrate
through mammary tissue as a result of
infection of the udder. Once within the cis-
terns, ducts and alveolar lumen of the gland,
phagocytosis by PMN and subsequent
degranulation may account for the negative
correlation between SCC and milk produc-
tion. Chemical compounds, such as ROS
released from neutrophils can cause mam-
mary secretory cell damage and reduced
milk yield. Substances secreted by the path-
ogen may also cause damage. Although
degranulation of neutrophils ensures the
potentiation of the inflammatory reaction,
it is usually undesirable in the very sensitive
mammary gland [97]. In order to minimise
mammary tissue damage and milk produc-
tion loss, elimination of invading bacteria
should proceed fast, probably rather because
of the side effects of the activated phago-
cytes and their ROS than because of a direct
effect of bacterial LPS.     
9.3. Do trafficking neutrophils cause 
damage?
The mechanism by which tissue damage
occurs during coliform mastitis is not yet
fully understood. Tissue damage caused by
neutrophils may originate from two sites:
intratissular or intraluminal. The damage
may originate from the inside of the paren-
chyma (intratissular), i.e. starting at the
basal side of the epithelium. Theoretically,
neutrophils trafficking in mammary tissue
towards the luminal side of the udder might
cause cell and tissue injury, especially
when it occurs massively, and mainly
through the release of mediators helping
them to traverse the different obstacles
(basal membranes, matrix and cells). It is
not clear whether transcellular epithelial
migration, as described for postcapillary
venular endothelial migration, occurs dur-
ing coliform mastitis [74]. Transcellular
endothelial neutrophil migration mainly
occurs through all or non-diaphragmed
fenestrated endothelia (to our best knowl-
edge, in the goat mammary gland, no such
fenestrations were found, [28]). Because
fenestrations are absent in mammary epi-
thelium this mechanism is not expected
in the mammary gland. However, a compa-
rable mechanism could occur. In the
inflamed gland some (damaged) epithelial
cells can be expelled by neutrophils into the
luminal surface of the ducts and cisterns to
create “a gap” [97] through which neu-
trophils could traverse massively into the
lumen under influence of a chemotactic
gradient that starts in the postcapillary
venules and increases toward this gap and
the site of the nidus of infection. The proc-
ess of venular migration starts around two
hours after infection and an additional two
to four hours is needed to reach the epithe-
lium of the teat sinus. In mammary paren-
chyma, where postcapillary venules are
closer to the milk alveolus, shorter times
could be reached [183]. 
If LPS is used to induce the inflamma-
tory response in the mammary gland, no
lesions develop, and the PMN move
between the epithelial cells and the tight
junctions to get into the lumen of the gland
[97]. This is in agreement with the finding
that the drop in milk production during LPS
mastitis is short lasting and that it is com-
pletely self-curing within 2–3 days depend-
ing on the dose [53]. We have the
experience that primary cultured bovine
mammary epithelial monolayers have var-
iable and underdeveloped intercellular
junctions compared to the in vivo situation.
However, neutrophil migration induced by
C5a did not change electric resistance over
the cell layer over a short period. More-
over, cell lysis or epithelial detachment
were not observed [216–218]. The above
mentioned findings are in agreement with
the basic concept that paracellular migra-
tion  of neutrophils is locally modulated
and  that release of proteolytic enzymes in
the matrix (e.g. elastase) does not occur.
Instead, elastase is only activated in the
cytoplasm-membrane at the end of the
pseudopodia [43, 106], probably to affect
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the cell junctions protein complex, cad-
herin/catenin. Boulanger et al. [22] demon-
strated activation of gelatinase activity in
isolated bovine neutrophils stimulated with
LPS and PMA. Nevertheless, no epithelial
cytotoxicity could be detected. This may
explain why aprotinin, a serine proteinase
inhibitor which inhibits the proteolytic
activity, had no effect on epithelial damage
in a culture of MAC-T cells. However, in
other models, tissue lesions have been
observed following neutrophil diapedesis.
For example, neutrophil-mediated injury to
gut epithelium leading to disruption of the
epithelial barrier function with consequent
organ dysfunction was studied in vitro,
using a colonic epithelial cell line. In this
model it was demonstrated that neutrophil-
derived proteases can mediate spatially
delimited disruption of epithelial apical
junctions during transmigration [82].
9.4. Intraluminal induced damage
Intraluminal induced damage originates
from the luminal part of the gland, in cis-
terns and ducts where cells and chemical
mediators of the host are released to elimi-
nate the invading bacteria around the nidus
of infection. As the inflammatory cascade
progresses and spreads to ducts and alve-
oli, it will extend over the gland and the
lumina. As a result, alveoli will be filled up
with harmful exudate. This is apparently
the most plausible explanation for the tis-
sue damage observed during E. coli masti-
tis. Gelatinases, especially milk matrix
metalloproteinases (MPP), that are known
to be involved in the degradation of the
blood-milk barrier, increase massively in
the exudate during LPS-induced mastitis.
The major source of MPP originates from
the neutrophils and the MPP changes are
concordant with the increase in SCC dur-
ing mastitis [193]. I.M. infusion of 108
intact or lysed PMN caused palpable signs
of inflammation for 24 h and leukocytosis
for 5 days [110]. A mammary explant
model was developed to assess mammary
tissue damage caused by normal PMN
function [38]. Tissue from the udder of lac-
tating Holsteins was cultured in the pres-
ence of intact or lysed PMN. PMN that
were allowed to phagocytose opsonised
zymosan were used. The observed cytolog-
ical damage included cell sloughing from
the basement membrane, pyknosis, cell
debris in luminal areas and epithelial vacu-
olation. The damage to mammary epithe-
lium caused by these treatments was
ranked as follows: phagocytosing PMN >
lysed PMN > intact PMN.  
To study the underlying pathway of tissue
damage caused by migrating neutrophils
during coliform mastitis (intratissular vs.
intraluminal) in vitro studies with primary
cell lines and MAC-T cells have been used.
Although the in vitro studies are challeng-
ing and promising for detailed research,
careful interpretation is needed not to
oversimplify the phenomenon when extra-
polating the results to the in vivo mastitis
situation where massive neutrophil diaped-
esis occurs and where many local physiolog-
ical homeostatic mechanisms are drastically
altered. For example, from both field and
experimental studies where E. coli was
infused I.M. in cows, there is the well-
known experience that sometimes red
blood cells can appear in the milk of the
inflamed quarters as a result of the dramatic
alteration in mammary blood flow and
microvascular integrity during mastitis
[245].
9.5. Cytotoxic mediators
Three groups of mediators have been
studied and attempts were made to dissoci-
ate these factors to assess their individual
potential for damaging the mammary epi-
thelium. (1) Antibacterial defence involves
activation of neutrophils generating ROS
capable of killing bacteria [91]. It was
observed that neutrophils promote tissue
injury and disturb mammary function via
ROS production. Host lipid peroxidation,
initiated by enzymes such as NADPH oxi-
dase and myeloperoxidase, occurs [260].
(2) Neutrophilic degranulation, during which
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release of proteases occurs as a result of
neutrophil trafficking or as a consequence
of their phagocytic activity, was also
shown to be cytotoxic [2, 22, 38, 135, 165,
172]. During phagocytosis lysosomes
migrate toward the particle being internal-
ised and lysosomal enzymes are released
before fusion of the pseudopodia is com-
pleted, resulting in the release of lysosomal
contents to the outside of the PMN [81].
(3) Brooker et al. [26] postulated that at
least two bacterial toxins are involved in
E. coli mastitis. I.M. administration of
purified commercial LPS (Boivin extrac-
tion) produced an intense inflammatory
reaction without any epithelial lesion.
Neutrophils appeared all over the surface
but were not associated with lesions. A
fresh filtrate of the medium in which
E. coli was growing during 18 h, elicited a
mild inflammatory response but scanning
electron microscopic examination showed
that there was extensive damage of the lin-
ing epithelium. Both layers of the epithe-
lium of the lactiferous sinus were lost four
hours after infusion. The basement mem-
brane was exposed at that time and by four
hours neutrophils also started to appear at
the lesions. The postulated cytotoxic agent
was not identified but was found to be heat
labile. The extensive damage to the ductu-
lar epithelium is presumably induced by
the unknown cytotoxic compound, pro-
duced by E. coli. It was further postulated
that the damage to the alveolar epithelium
may not have the same genesis [79]. For
the most severe cases, where all lactiferous
sinus epithelia are lost and where intersti-
tial tissue became totally haemorrhagic
[97] it was postulated that the LPS mole-
cule might be responsible for the profound
circulatory disturbances [79]. 
In a recent study, LPS and PMA were not
found to be toxic to MAC-T cells, whereas
the amino acid histidine ( 6 mg/mL) was
found to be toxic to mammary secretory
epithelial cells. Together, histidine and
500 000 activated PMN/mL were also toxic
[135]. As a consequence, the effect of anti-
oxidants was investigated on the neutrophil
induced epithelial damage in vitro. The
model consisted of a co-culture of MAC-T
cells with isolated bovine neutrophils.
PMA-activated neutrophils in combination
with E. coli endotoxins caused release of
superoxide. Epithelial damage was also
observed [22, 135]. Melatonin that scav-
enges hydroxyl radicals and peroxynitrite
reduced neutrophil-induced cytotoxicity
dose-dependently [22]. 
9.6. Effect of rbST on milk loss during 
mastitis
The above mentioned findings inspired
investigators to evaluate the potential pro-
tective effects of recombinant bovine
somatotropin (rbST) during coliform mas-
titis, because during this disease the neu-
trophil plays a pivotal role in its outcome
[244]. In a first study, 19 cows, classified as
moderate or severe responders (based on
the respiratory burst activity of blood neu-
trophils before challenge), were treated
with rbST or vehicle, 48 h after I.M. inoc-
ulation of E. coli. Clinical status and
changes in milk production and composi-
tion were compared in the four groups. In a
second study, 8 cows received rbST or
vehicle 7 days before bacterial challenge.
The decrease in milk synthesis was accom-
panied by increased milk sodium and chlo-
ride and decreased potassium and lactose
concentrations (Fig. 7, [29]). The latter
indicates the opening of tight junctions
between mammary epithelial cells, which
occurs during inflammation of the mam-
mary gland of ruminants [28]. The decrease
in lactose concentration is also the result of
its altered synthesis which is, in part, due to
the decreased synthesis of -lactalbumin
[93]. Milk production of rbST cows recov-
ered better than that of placebo cows.
Recovery of milk components, such as lac-
tose (Fig. 7), was accelerated in severe
responders treated with rbST, but not in
moderate responders. Pre-treatment of
severe responders with rbST enhanced
milk production before infection, protected
the mammary glands from excessive loss
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of milk during the subsequently induced
coliform mastitis, and accelerated normal-
isation of milk composition. It was con-
cluded that: (1) the beneficial effects of
rbST upon normalisation of milk produc-
tion and composition was restricted to
severe responders; (2) the beneficial effects
of the treatment with rbST was most pro-
nounced on milk composition in infected
glands. The acceleration of the tightening
of the blood-milk barrier was spectacular;
the gain in milk production was less pro-
nounced. This might suggest that rbST (or
IGF-I) increases milk production in the
diseased gland, partly by inhibiting epithe-
lial cell loss and/or restoring cellular
differentiation. In a T84 cell monolayer
model it was demonstrated that IGF-I and
IGF-II regulate the paracellular permeabil-
ity through a receptor-mediated process
that probably involves changes in protein
synthesis and cytoskeletal structure [155].
(3) In severe responders that had been
treated with rbST, changes observed during
mastitis resembled those in moderate
responders treated with the placebo. The
exact mechanism of how rbST affects the
recovery of the secretory epithelium during
mastitis remains unknown. During coli-
form mastitis bST concentration is higher
in challenged cows, IGF-I increases in
whey of the infected glands [34, 209], and
IGF binding proteins also increase in the
whey of infected glands [209]. The endog-
enous release of bST and IGF-I during
mastitis might be considered as a homeo-
static mechanism involved in the resolution
of the inflammatory response. It is also
possible that rbST increased the rate of cell
renewal in the lactating mammary gland as
it does during normal lactation [39]. The
rbST or its intermediary IGF that increases
in milk whey during mastitis, may have
interfered with apoptotic factors that are
released during mastitis and that induce
cell death. It is also not excluded that rbST
may have had an indirect effect on mastitis
through enhancing the defence system of
the cow [34]. Elvinger et al. [71] showed
that administration of rbST to cows
increased lymphocyte blastogenesis but
not phagocytosis and killing of E. coli
by PMN. Recombinant human growth
hormone primes human neutrophils for
enhanced superoxide anion secretion [80].
The possible effect of rbST was also
studied during S. uberis mastitis, another
environmental mastitis type. Cows were
treated with long acting rbST 7 days before
Figure 7.  Milk lactose concentrations in infected quarters of rbST treated (, n = 7) and control (,
n = 10) cows with acute E. coli mastitis in early lactation. (Figure taken from the original paper [29],
with permission.)
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and after infection and compared with
control cows that received the excipient.
Comparable results were obtained. Soma-
totropin protected the mammary gland
from excessive production losses. It also
significantly improved the normalisation of
composition, indicating a beneficial effect
on the restoration of the integrity of the
blood-milk barrier [100]. Also in this
model, rbST treatment induced signifi-
cantly higher IGF-I and rbST concentra-
tions in plasma. Despite these positive
effects on milk production and composi-
tion, no effect on some defence parameters
such as chemiluminescence, rate of diape-
desis and the expression of adhesion recep-
tors of circulating PMN could be detected
[99]. 
9.7. Lesions in rare cases of atypical 
E. coli mastitis
The pathogenesis of atypical cases of
E. coli mastitis falls beyond the scope of
this review. It is however interesting to
focus on some particular characteristics.
Sometimes a delayed PMN infiltration
results in a failure to eliminate the bacteria.
Pathogens and PMN co-exist for many
days, with a gradual increase in the propor-
tion of mononuclear cells in the secretion,
which are themselves less efficient at kill-
ing bacteria [48]. In these cases dramatic
epithelial hyperplasia occurs. The secre-
tory function of the gland is lost or severely
impaired. Two strains of E. coli, isolated
from the milk of two different cows suffer-
ing from persistent E. coli mastitis were
tested for adhesion to and invasion of three
primary mammary epithelial cell cultures
derived from mammary biopsies of the two
infected cows. Here, intracellular E. coli
were detected during five days post-infec-
tion in vitro. Histology of mammary tissue
revealed chronic inflammatory changes in
quarters that were persistently infected
by E. coli but in contrast to the in vitro
situation, intracellular bacteria were not
detected in mammary tissue sections [67]. 
10. CONCLUSION
From both epidemiological and experi-
mental studies it can be concluded that
severity of coliform mastitis is of much
more concern than its incidence. Moreover,
from many recent studies it appears that the
severity of E. coli mastitis is mainly related
to “host factors” rather than to the pathogen
itself. The periparturient period, the early
stage of lactation, parity, hormonal and
metabolic alterations, and negative energy
balance may affect PMN function and
bactericidal efficiency in blood and the
mammary gland of the dairy cow. The
PMN dysfunction influences the balance
between the inflammatory reactions, bacte-
ricidal capacity and tissue damage, boost-
ing the severity of E. coli mastitis. This
dysfunction may originate at the level of
the bone marrow, the blood circulation and/
or the mammary gland. In dairy cows the
severity of E. coli mastitis is more likely
during early lactation and more pro-
nounced in older cows.  Any management
strategy that aims to influence the severity
of E. coli mastitis in dairy cows should be
focused on both the dry and periparturient
period. Moreover, this strategy should be
directed towards minimizing energy and
environmental stress. Some genetic factors
might also be involved temporarily. It is
possible that as a result of parturition, neg-
ative energy balance, etc., certain genes are
(or are not) expressed during the beginning
of lactation. Optimisation of the bacteri-
cidal capacity of PMN and diminishing tis-
sue damage during E. coli mastitis is a
challenge for research in the near future. 
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